A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
for Extensive Stage Small Cell Lung Cancer
Drug: Tarlatamab
13 locations incl. Gilbert
Sponsor: Amgen
Sex: All·Age: 18 - 90
Code: NCT07037758·Phase 1·Recruiting